DE-PLAN E: Evaluation of the Translation of the DE-PLAN Program for the Primary Prevention of Type 2 Diabetes in Routine Primary Care

Sponsor
Basque Health Service (Other)
Overall Status
Completed
CT.gov ID
NCT01365013
Collaborator
(none)
1,113
1
2
49
22.7

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the feasibility and effectiveness of the DE-PLAN Euskadi program for the primary prevention of type-II diabetes in high-risk population seen in primary care centers (Osakidetza-Basque Health Service) in which such intervention is implemented, compared to usual care control centers.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: DE-PLAN
  • Behavioral: Control group
Phase 4

Detailed Description

Objective: To evaluate the feasibility and effectiveness of the DE-PLANЄ program for the primary prevention of type-II diabetes in high-risk population seen in primary care centers (Osakidetza) in which such intervention is implemented, compared to usual care control centers.

DESIGN AND METHODS: A phase IV cluster randomized prospective clinical trial, conducted in 14 primary care centers from Osakidetza, which will be randomly assigned to intervention or control group, that will collect a sample of 2534 followed for two years, aged 45 to 70 years without diabetes but with high risk of developing it (FINDRISC scale> 14), identified by a screening system. Nurses in intervention centers (GI) will implement DEPLANЄ for 12 months, a structured educational intervention on healthy lifestyles (diet and physical activity), while patients of the control centers will receive standard care for the prevention and treatment of type-II diabetes.

ANALYSIS: The feasibility will be reported as the reach, adoption and implementation of the program. The attributable effectiveness of the program will be determined by comparing the changes in the incidence and risk of developing diabetes in healthy habits quality of life, observed in patients exposed to DE-PLANЄ intervention and of patients from control centers. The incremental cost-utility of DE-PLANЄ program will be also analysed.

Study Design

Study Type:
Interventional
Actual Enrollment :
1113 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effectiveness of the Translation of a Type 2 Diabetes Primary Prevention Program in Routine Context of Primary Heath Care
Study Start Date :
Jun 1, 2011
Actual Primary Completion Date :
Jun 1, 2013
Actual Study Completion Date :
Jul 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lifestyle counseling

Behavioral: DE-PLAN
structured group or individual educational sessions (4 to 5) on diet and physical activity, plus ongoing reminder contacts (e-mails, sms, etc) during 1 year

Active Comparator: control group

Behavioral: Control group
Standard advice for lifestyle change

Outcome Measures

Primary Outcome Measures

  1. Adoption of healthy lifestyles [12 months]

    Change in the adoption of minimum recommended levels of physical activity and fruit and vegetable consumption

  2. Incidence of Diabetes [24 months]

    Effectiveness of the program in the reduction of the Incidence of Diabetes

Secondary Outcome Measures

  1. Reach of the program [24 months]

    Percentage of eligible participants exposed to the program

  2. Implementation of the program [24 months]

    Extent in which the intervention components have been delivered as intended (intervention protocol)

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 45 to 70 years old

  • high risk of developing type-II diabetes (Findrisc scale > 14 points)

Exclusion Criteria:
  • Disorders of the cardiovascular system

  • Transplant recipients

  • Renal or hepatic failure

  • Severe chronic obstructive pulmonary disease

  • Severe mental disorders

  • Chronic and acute severe infections

  • Metabolic uncontrolled disorders

  • Restrictive pathology of muscles, bones and joints

  • Complicated pregnancy

  • Contact difficulties

Contacts and Locations

Locations

Site City State Country Postal Code
1 Primary Care Research Unit of Bizkaia Bilbao Spain E48014

Sponsors and Collaborators

  • Basque Health Service

Investigators

  • Principal Investigator: Carmen Silvestre, Basque Health Service
  • Principal Investigator: Alvaro Sanchez, Basque Health Service

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Carmen Silvestre Busto, Nurse, Basque Health Service
ClinicalTrials.gov Identifier:
NCT01365013
Other Study ID Numbers:
  • 2010111039
First Posted:
Jun 3, 2011
Last Update Posted:
Jul 29, 2016
Last Verified:
Jul 1, 2016
Keywords provided by Carmen Silvestre Busto, Nurse, Basque Health Service
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2016